These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2706626)

  • 21. Additive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines.
    Engblom P; Rantanen V; Kulmala J; Helenius H; Grènman S
    Br J Cancer; 1999 Jan; 79(2):286-92. PubMed ID: 9888470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination effects of TAS-103, a novel dual topoisomerase I and II inhibitor, with other anticancer agents on human small cell lung cancer cells.
    Sunami T; Nishio K; Kanzawa F; Fukuoka K; Kudoh S; Yoshikawa J; Saijo N
    Cancer Chemother Pharmacol; 1999; 43(5):394-401. PubMed ID: 10100595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro.
    Raitanen M; Rantanen V; Kulmala J; Helenius H; Grénman R; Grénman S
    Int J Cancer; 2002 Jul; 100(2):238-43. PubMed ID: 12115575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines.
    Kaufmann SH; Peereboom D; Buckwalter CA; Svingen PA; Grochow LB; Donehower RC; Rowinsky EK
    J Natl Cancer Inst; 1996 Jun; 88(11):734-41. PubMed ID: 8637027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different interaction of cisplatin and etoposide on in vivo and in vitro tumor systems.
    Soranzo C; Pratesi G; Zunino F
    Anticancer Drugs; 1990 Oct; 1(1):23-8. PubMed ID: 2131031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combination effects of etoposide with other antitumor drugs in vitro and in vivo].
    Nishikawa K; Kusama K; Ekimoto H; Takahashi K
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3739-45. PubMed ID: 2596858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumoricidal interactions of hyperthermia with carboplatin, cisplatin and etoposide.
    Cohen JD; Robins HI; Schmitt CL
    Cancer Lett; 1989 Mar; 44(3):205-10. PubMed ID: 2647285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combination effect of pentoxifylline and etoposide on a human lung cancer cell line].
    Ishida S; Fujiuchi S; Akiba Y; Osanai S; Tsuji T; Nakano H; Matsumoto H; Ohosaki Y; Fujikane T; Onodera S
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1217-20. PubMed ID: 2053781
    [No Abstract]   [Full Text] [Related]  

  • 29. Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine.
    Greco WR; Park HS; Rustum YM
    Cancer Res; 1990 Sep; 50(17):5318-27. PubMed ID: 2386940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships between various uses of antineoplastic drug-interaction terms.
    Wampler GL; Carter WH; Campbell ED; Keefe PA
    Cancer Chemother Pharmacol; 1992; 31(2):111-7. PubMed ID: 1333367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supra-additive cytotoxic effects of a combination of cytostatic drugs and antibody-induced complement activation on tumor cells in vitro.
    Brezicka T; Einbeigi Z
    Tumour Biol; 2001; 22(2):97-103. PubMed ID: 11125282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etoposide prior to cis-diamminedichloroplatinum in combination chemotherapy: in vitro and in vivo studies.
    Zupi G; Greco C; Sacchi A; Calabresi F
    Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1501-6. PubMed ID: 3830728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of synergism by a novel three-dimensional model for the combined action of cisplatin and etoposide on the growth of a human small-cell lung-cancer cell line, SBC-3.
    Kanzawa F; Nishio K; Fukuoka K; Fukuda M; Kunimoto T; Saijo N
    Int J Cancer; 1997 May; 71(3):311-9. PubMed ID: 9139860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic and antagonistic combinations of drugs in human prostate cancer cell lines in vitro.
    Budman DR; Calabro A; Kreis W
    Anticancer Drugs; 2002 Nov; 13(10):1011-6. PubMed ID: 12439335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic cytotoxicity using 2'-deoxy-5-azacytidine and cisplatin or 4-hydroperoxycyclophosphamide with human tumor cells.
    Frost P; Abbruzzese JL; Hunt B; Lee D; Ellis M
    Cancer Res; 1990 Aug; 50(15):4572-7. PubMed ID: 1695122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of in vitro chemosensitivity using human lung cancer cell lines.
    Kratzke RA; Kramer BS
    J Cell Biochem Suppl; 1996; 24():160-4. PubMed ID: 8806098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibitory Effects of Etoposide Combined with 8-methoxypsoral en on Highly Metastatic Human Mucoepidermoid Carcinoma Cells].
    Li Y; Wu J; Situ Z; Liu B; Han J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Nov; 17(4):335-7, 345. PubMed ID: 12545969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxyurea and etoposide: in vitro synergy and phase I clinical trial.
    Ratain MJ; Schilsky RL; Wojack BR; Simon T; Senekjian EK; Vogelzang NJ
    J Natl Cancer Inst; 1988 Nov; 80(17):1412-6. PubMed ID: 3270508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin synergistically enhances antiproliferative effects of cisplatin and etoposide in NCI-H460 human lung cancer cells.
    Teixeira SF; Guimarães Idos S; Madeira KP; Daltoé RD; Silva IV; Rangel LB
    J Bras Pneumol; 2013; 39(6):644-9. PubMed ID: 24473757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of the antitumoural pyridyl cyanoguanidine CHS 828 and etoposide in vitro--from cytotoxic synergy to complete inhibition of apoptosis.
    Martinsson P; Ekelund S; Nygren P; Larsson R
    Br J Pharmacol; 2002 Oct; 137(4):568-73. PubMed ID: 12359640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.